GENMAB AS SP.ADR/1/10DK 1 (GE91) — Free Cash Flow Generation Index
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of €288.00 Million represents 1% of operating cash flow (€301.00 Million). Explore GE91 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GENMAB AS SP.ADR/1/10DK 1 Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. For the full cash flow conversion analysis, see GENMAB AS SP.ADR/1/10DK 1 cash conversion from operations.
Annual Free Cash Flow Generation for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Year-by-year Free Cash Flow Generation Index for GENMAB AS SP.ADR/1/10DK 1. Check GE91 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | €1.13 Billion | €1.19 Billion | €55.00 Million | ▼ -0.8% |
| 2024 | 0.96x | €1.04 Billion | €1.08 Billion | €42.41 Million | ▲ +1.2% |
| 2023 | 0.95x | €1.04 Billion | €1.10 Billion | €55.83 Million | ▲ +3.3% |
| 2022 | 0.92x | €517.42 Million | €563.05 Million | €45.63 Million | ▲ +3.6% |
| 2021 | 0.89x | €300.82 Million | €339.18 Million | €38.36 Million | — |